What is NDC 23155-893?

23155-893 is the product NDC for Methohexital Sodium, Methohexital sodium 500 mg/500mg injection, listed with the FDA by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., NDC labeler code 23155. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Methohexital Sodium?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Methohexital Sodium NDC 23155-893 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)23155-893Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23155-0893Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
23155-893-31	2315508933123155089331	1 VIAL in 1 CARTON (23155-893-31) / 500 mg in 1 VIALMarketed from Dec 12, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methohexital Sodium
Generic name (nonproprietary): methohexital sodium
Active ingredients: Methohexital sodium — 500 mg/500mg
Dosage form: Injection
Route: Intramuscular, Intravenous, Rectal
Labeler: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.NDC labeler code 23155
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215488
Marketing start: Dec 12, 2024
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Barbiturates (Chemical structure)
Identifiers: Product ID 23155-893_8dd0a3ad-e10f-4877-84f2-9a39960e534dSPL ID 8dd0a3ad-e10f-4877-84f2-9a39960e534dSPL set ID f76d4ab9-2f6c-420b-afec-b9cdfdc083ceRxCUI 1244233UNII 60200PNZ7QUPC 0323155893311, 0011100004492
Pharmacologic class: Barbiturate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N423155089331 followed by a unit qualifier and the quantity

Package 23155-0893-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methohexital Sodium for Injection can be used in adults as follows: For intravenous induction of anesthesia prior to the use of other general anesthetic agents. For intravenous induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for short surgical procedures; Methohexital Sodium for Injection may be given by infusion or intermittent injection. For use along with other parenteral agents, usually narcotic analgesics, to supplement subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for longer surgical procedures. As intravenous anesthesia for short surgical, diagnostic, or therapeut…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 23155-893

What is NDC 23155-893?: 23155-893 is the product NDC for Methohexital Sodium, Methohexital sodium 500 mg/500mg injection, listed with the FDA by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Methohexital Sodium.
What is the active ingredient?: Methohexital sodium.
Who is the labeler?: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., NDC labeler code 23155. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Methohexital Sodium?: 1 other product NDC are listed under this name. See all Methohexital Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Methohexital Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Methohexital Sodium	Methohexital sodium 500 mg/500mg	InjectionIntravenous	ONESOURCE SPECIALTY PHARMA LIMITED	83270-003	83270-0003-01

Other NDCs under ANDA 215488

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215488
Product	Strength	Form · route	Labeler	Product NDC
Methohexital Sodium	Methohexital sodium 500 mg/500mg	InjectionIntravenous	ONESOURCE SPECIALTY PHARMA LIMITED	83270-003